Infection

Papers
(The H4-Index of Infection is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Long COVID, a comprehensive systematic scoping review209
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore128
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia111
COVID-19 and mucormycosis superinfection: the perfect storm107
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe106
Long COVID: current definition105
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis103
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit89
C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-1988
Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg85
Clinical and virological features of first human monkeypox cases in Germany81
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies72
Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect68
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence68
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia64
COVID-19: persistence of symptoms and lung alterations after 3–6 months from hospital discharge58
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study53
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis53
Antibiotics in the pipeline: a literature review (2017–2020)53
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?49
CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity48
Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis47
The current therapeutical strategies in human brucellosis46
Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury45
IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection44
SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-1943
Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values42
Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis41
Monkeypox in-patients with severe anal pain41
Characteristics of viral pneumonia in the COVID-19 era: an update39
Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation?38
The rising of old foes: impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infections37
Preoperative synovial fluid culture poorly predicts the pathogen causing periprosthetic joint infection36
Severe monkeypox-virus infection in undiagnosed advanced HIV infection36
Herpes zoster and COVID-19 infection: a coincidence or a causal relationship?35
0.054318904876709